Release of Growth Factors, Cytokines and Therapeutic Molecules by Hyaluronan-based Hydrogels

被引:0
作者
Peattie, Robert A. [1 ]
机构
[1] Tufts Univ, Dept Biomed Engn, Ctr Sci & Technol, Medford, MA 02155 USA
基金
美国国家科学基金会;
关键词
Hyaluronan; hydrogels; cytokines; growth factors; biomaterials; IN-VIVO ANGIOGENESIS; SYNTHETIC EXTRACELLULAR MATRICES; DRUG-DELIVERY; SUSTAINED-RELEASE; GLYCOSAMINOGLYCAN HYDROGELS; SODIUM HYALURONATE; ACID HYDROGEL; INTRAUTERINE ADHESIONS; CHEMICAL-MODIFICATION; PROTEIN DELIVERY;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hyaluronan (HA) is a highly biocompatible biopolymer that is widely used for a variety of therapeutic purposes including surgical preparations, adhesion prevention, viscosupplementation and drug and cytokine delivery. Delivery can be accomplished effectively when HA-based carriers are synthesized in the form of hydrogels, though doing so normally requires chemical modification of the native HA structure. Solute delivery from HA-based gels can be either "simple", that is from a gel not including separate components intended to control release, or "regulated" when specific components are included for that purpose. A variety of modified forms of HA have been developed and used for delivery of desired molecules in therapeutic, clinical, veterinary and laboratory research environments, and the number of such applications is likely to grow in future years.
引用
收藏
页码:1299 / 1305
页数:7
相关论文
共 74 条
[1]   Effectiveness of auto-cross-linked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic adhesiolysis: a prospective, randomized, controlled study [J].
Acunzo, G ;
Guida, M ;
Pellicano, M ;
Tommaselli, GA ;
Sardo, AD ;
Bifulco, G ;
Cirillo, D ;
Taylor, A ;
Nappi, C .
HUMAN REPRODUCTION, 2003, 18 (09) :1918-1921
[2]   Targeting to macrophages:: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages [J].
Ahsan, FL ;
Rivas, IP ;
Khan, MA ;
Suárez, AIT .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :29-40
[3]  
Aly Maha Nasr Sayed, 2008, Recent Pat Drug Deliv Formul, V2, P231
[4]  
Anthony E.T., 2006, Drug Discovery Today: Therapeutic Strategies, V3, P81, DOI DOI 10.1016/J.DDSTR.2006.03.001
[5]  
Band PA, 1998, WENN GR INT, V72, P33
[6]   An injectable drug delivery platform for sustained combination therapy [J].
Baumann, M. Douglas ;
Kang, Catherine E. ;
Stanwick, Jason C. ;
Wang, Yuanfei ;
Kim, Howard ;
Lapitsky, Yakov ;
Shoichet, Molly S. .
JOURNAL OF CONTROLLED RELEASE, 2009, 138 (03) :205-213
[7]   Wound healing dressings and drug delivery systems: A review [J].
Boateng, Joshua S. ;
Matthews, Kerr H. ;
Stevens, Howard N. E. ;
Eccleston, Gillian M. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (08) :2892-2923
[8]   Adhesion reduction after knee surgery in a rabbit model by Hyaloglide®, a hyaluronan derivative gel [J].
Brunelli, G ;
Longinotti, C ;
Bertazzo, C ;
Pavesio, A ;
Pressato, D .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2005, 23 (06) :1377-1382
[9]   Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor [J].
Cai, SS ;
Liu, YC ;
Shu, XZ ;
Prestwich, GD .
BIOMATERIALS, 2005, 26 (30) :6054-6067
[10]   Semisynthetic resorbable materials from hyaluronan esterification [J].
Campoccia, D ;
Doherty, P ;
Radice, M ;
Brun, P ;
Abatangelo, G ;
Williams, DF .
BIOMATERIALS, 1998, 19 (23) :2101-2127